Onurcan Sahin

Title: Onurcan Sahin: Innovator in Lens Capsule Reconstruction

Introduction

Onurcan Sahin is a prominent inventor based in Istanbul, Turkey. He has made significant contributions to the field of ophthalmology, particularly in the development of devices for lens capsule reconstruction after cataract surgery. With a total of 4 patents to his name, Sahin is recognized for his innovative approach to improving surgical outcomes for patients.

Latest Patents

Sahin's latest patents focus on devices designed to reconstruct a natural lens capsule following cataract surgery. These devices feature a ring-shaped rigid component and a ring-shaped flexible component, along with a groove on the inner surface of the rigid component. The rigid component's distal end is attached to the flexible component, while its proximal end rests against Wieger's ligament when positioned within the natural lens capsule. The flexible component's distal end contacts the anterior surface of the lens capsule, ensuring a secure fit. The groove is specifically designed to accommodate the optics of an intraocular lens and to secure the haptics.

Career Highlights

Sahin has established himself as a key figure in the medical device industry, particularly through his work at Eye-PCR B.V. His innovative designs and patents have the potential to enhance the quality of life for individuals undergoing cataract surgery. His commitment to advancing medical technology is evident in his ongoing research and development efforts.

Collaborations

Throughout his career, Onurcan Sahin has collaborated with esteemed colleagues such as Ioannis G. Pallikaris and Harilaos Ginis. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of ophthalmology.

Conclusion

Onurcan Sahin's contributions to lens capsule reconstruction demonstrate his dedication to innovation in medical technology. His patents and collaborative efforts continue to pave the way for advancements in cataract surgery, ultimately benefiting patients worldwide.